95 related articles for article (PubMed ID: 28690214)
41. miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.
Cui X; Li Q; He Y
Mol Cell Biochem; 2017 Jan; 424(1-2):195-201. PubMed ID: 27822662
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
Yunqiao L; Vanke H; Jun X; Tangmeng G
Hepatogastroenterology; 2014; 61(133):1302-7. PubMed ID: 25436301
[TBL] [Abstract][Full Text] [Related]
43. Effect of microRNA-1 on hepatocellular carcinoma tumor endothelial cells.
Hu C; Shen SQ; Cui ZH; Chen ZB; Li W
World J Gastroenterol; 2015 May; 21(19):5884-92. PubMed ID: 26019452
[TBL] [Abstract][Full Text] [Related]
44. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism].
Lin F; Yan W; Wen T; Wu GY
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):742-6. PubMed ID: 24378094
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells.
Liang HH; Wei PL; Hung CS; Wu CT; Wang W; Huang MT; Chang YJ
Tumour Biol; 2013 Oct; 34(5):3209-18. PubMed ID: 23760980
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-98 sensitizes cisplatin-resistant human lung adenocarcinoma cells by up-regulation of HMGA2.
Xiang Q; Tang H; Yu J; Yin J; Yang X; Lei X
Pharmazie; 2013 Apr; 68(4):274-81. PubMed ID: 23700794
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42.
Gao M; Liu L; Li S; Zhang X; Chang Z; Zhang M
Oncol Rep; 2015 Nov; 34(5):2523-32. PubMed ID: 26352279
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.
Sun KX; Jiao JW; Chen S; Liu BL; Zhao Y
J Ovarian Res; 2015 Dec; 8():80. PubMed ID: 26626440
[TBL] [Abstract][Full Text] [Related]
49. [Potentiation of cisplatin induced apoptosis by low molecular weight heparin in human hepatocellular carcinoma cell].
Wu W; Yu B; Geng Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 40(12):1298-305. PubMed ID: 26739070
[TBL] [Abstract][Full Text] [Related]
50. miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.
O'Brien K; Lowry MC; Corcoran C; Martinez VG; Daly M; Rani S; Gallagher WM; Radomski MW; MacLeod RA; O'Driscoll L
Oncotarget; 2015 Oct; 6(32):32774-89. PubMed ID: 26416415
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
[TBL] [Abstract][Full Text] [Related]
52. [Potentiation and mechanism of cisplatin-induced apoptosis by lidamycin in human hepatoma BEL-7402 cells].
Liu HZ; Li DD; Zhen YS; Shao RG
Yao Xue Xue Bao; 2003 Apr; 38(4):250-4. PubMed ID: 12889121
[TBL] [Abstract][Full Text] [Related]
53. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
[TBL] [Abstract][Full Text] [Related]
54. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
[TBL] [Abstract][Full Text] [Related]
55. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
Huang GH; Shan H; Li D; Zhou B; Pang PF
Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line.
Ziyan W; Yang L
Ir J Med Sci; 2016 Feb; 185(1):85-91. PubMed ID: 25381586
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-363-3p is downregulated in hepatocellular carcinoma and inhibits tumorigenesis by directly targeting specificity protein 1.
Ying J; Yu X; Ma C; Zhang Y; Dong J
Mol Med Rep; 2017 Aug; 16(2):1603-1611. PubMed ID: 28627662
[TBL] [Abstract][Full Text] [Related]
58. [miR-15a and miR-16 modulate drug resistance by targeting bcl-2 in human colon cancer cells].
Xu M; Zhou B; Wang G; Wang G; Weng X; Cai J; Li P; Chen H; Jiang X; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):897-902. PubMed ID: 25623762
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
60. miR-26a promoted by interferon-alpha inhibits hepatocellular carcinoma proliferation and migration by blocking EZH2.
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Genet Test Mol Biomarkers; 2015 Jan; 19(1):30-6. PubMed ID: 25494962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
